Call Us Contact Us
+44 1494 818 000     Online Enquiry
Lines open
Monday to Thursday
08:30 to 18:00
Friday
08:30 to 17:30
Pharmaceutical | Medical Devices | Scientific | Consumer Healthcare | Dental | Animal Health
Healthcare Communications | Pharmaceutical Executive | Medical Executive | Tech PR | Scientific Executive
         
Latest Jobs
Exclusive vacancies may not be shown here, please contact Mark on +44 1494 818 049 or markd@zenopa.com for more information.
Have you registered?
Once you register you can see additional job details, save jobs, track your applications and manage e-lert preferences.

Register now
Mark Denton
Managing Director
markd@zenopa.com
+44 1494 818 049

Testimonials
I just wanted to thank you and the rest of the team for all your help and support in enabling me to gain my new role.
Sally, 2011

Schering-Plough to launch new OTC heartburn medication

6 April 2010 00:00 in Pharmacy Supplier News


Schering-Plough is to launch a new over-the-counter (OTC) heartburn treatment, which combines two active ingredients to deliver relief from the condition.

The company's new Zegerid OTC product is a 14-day course of treatment which has been approved by regulators and is being marketed as part of an agreement with Santarus.

It utilises the active ingredient omeprazole to reduce acid levels, while its sodium bicarbonate content protects the other ingredient from degradation by stomach acid, allowing for maximum absorption.

Bridgette Heller, president of Schering-Plough Consumer HealthCare, expressed confidence that the new product will match the success of other OTC brands such as Claritin and Lotrimin.

She added: "With its strong history as an effective prescription product, we are excited to bring Zegerid OTC directly to consumers."

Schering-Plough has been a part of Merck Sharpe and Dohme since the two firms completed their merger towards the end of last year.

Other news stories from 06/04/2010

Related news

Read more in the Zenopa News Archive

How this news is generated

Story collated for Zenopa by the Axonn News Agency



                    
© Copyright 2014 Zenopa Ltd